nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosamprenavir—CYP3A4—Sibutramine—obesity	0.194	0.27	CbGbCtD
Fosamprenavir—CYP3A4—Benzphetamine—obesity	0.147	0.204	CbGbCtD
Fosamprenavir—CYP3A4—Bupropion—obesity	0.125	0.174	CbGbCtD
Fosamprenavir—CYP3A4—Orlistat—obesity	0.102	0.142	CbGbCtD
Fosamprenavir—CYP3A4—Cimetidine—obesity	0.0917	0.127	CbGbCtD
Fosamprenavir—CYP3A4—Topiramate—obesity	0.06	0.0835	CbGbCtD
Fosamprenavir—Hypertrophy of breast—Bupropion—obesity	0.00853	0.0312	CcSEcCtD
Fosamprenavir—Reaction gastrointestinal—Orlistat—obesity	0.00714	0.0261	CcSEcCtD
Fosamprenavir—Autoimmune disorder—Orlistat—obesity	0.00714	0.0261	CcSEcCtD
Fosamprenavir—Drug hypersensitivity—Bupropion—obesity	0.00499	0.0182	CcSEcCtD
Fosamprenavir—Paraesthesia oral—Sibutramine—obesity	0.00492	0.018	CcSEcCtD
Fosamprenavir—Paraesthesia oral—Bupropion—obesity	0.00429	0.0157	CcSEcCtD
Fosamprenavir—Loose stools—Bupropion—obesity	0.00363	0.0133	CcSEcCtD
Fosamprenavir—Breast enlargement—Sibutramine—obesity	0.00355	0.013	CcSEcCtD
Fosamprenavir—Hyperlipidaemia—Sibutramine—obesity	0.0032	0.0117	CcSEcCtD
Fosamprenavir—Breast enlargement—Bupropion—obesity	0.0031	0.0113	CcSEcCtD
Fosamprenavir—Acute coronary syndrome—Phentermine—obesity	0.00287	0.0105	CcSEcCtD
Fosamprenavir—Myocardial infarction—Phentermine—obesity	0.00286	0.0104	CcSEcCtD
Fosamprenavir—Paraesthesia oral—Topiramate—obesity	0.00273	0.00998	CcSEcCtD
Fosamprenavir—Neutropenia—Cimetidine—obesity	0.00253	0.00925	CcSEcCtD
Fosamprenavir—Hypercholesterolaemia—Sibutramine—obesity	0.00244	0.00891	CcSEcCtD
Fosamprenavir—Stevens-Johnson syndrome—Cimetidine—obesity	0.00239	0.00874	CcSEcCtD
Fosamprenavir—Anorexia—Benzphetamine—obesity	0.00238	0.00869	CcSEcCtD
Fosamprenavir—Inflammation—Sibutramine—obesity	0.00238	0.00868	CcSEcCtD
Fosamprenavir—Rhabdomyolysis—Bupropion—obesity	0.00227	0.0083	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Methamphetamine—obesity	0.00223	0.00817	CcSEcCtD
Fosamprenavir—Gastrooesophageal reflux disease—Bupropion—obesity	0.00222	0.00813	CcSEcCtD
Fosamprenavir—Decreased appetite—Benzphetamine—obesity	0.00217	0.00793	CcSEcCtD
Fosamprenavir—Anorexia—Phendimetrazine—obesity	0.00217	0.00792	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Benzphetamine—obesity	0.00215	0.00787	CcSEcCtD
Fosamprenavir—Hypercholesterolaemia—Bupropion—obesity	0.00212	0.00776	CcSEcCtD
Fosamprenavir—Erythema multiforme—Cimetidine—obesity	0.00205	0.00749	CcSEcCtD
Fosamprenavir—Diabetes mellitus—Orlistat—obesity	0.00199	0.00726	CcSEcCtD
Fosamprenavir—Decreased appetite—Phendimetrazine—obesity	0.00198	0.00723	CcSEcCtD
Fosamprenavir—Calculus of kidney—Topiramate—obesity	0.00195	0.00714	CcSEcCtD
Fosamprenavir—Diabetes mellitus—Sibutramine—obesity	0.00192	0.00703	CcSEcCtD
Fosamprenavir—Hypersensitivity—Methamphetamine—obesity	0.00191	0.00697	CcSEcCtD
Fosamprenavir—Flatulence—Cimetidine—obesity	0.00186	0.00679	CcSEcCtD
Fosamprenavir—Hypersensitivity—Benzphetamine—obesity	0.00184	0.00672	CcSEcCtD
Fosamprenavir—Abdominal pain—Phendimetrazine—obesity	0.0018	0.00657	CcSEcCtD
Fosamprenavir—Hyperlipidaemia—Topiramate—obesity	0.00178	0.00649	CcSEcCtD
Fosamprenavir—Diarrhoea—Methamphetamine—obesity	0.00177	0.00647	CcSEcCtD
Fosamprenavir—Dizziness—Methamphetamine—obesity	0.00171	0.00625	CcSEcCtD
Fosamprenavir—Diarrhoea—Benzphetamine—obesity	0.00171	0.00624	CcSEcCtD
Fosamprenavir—Myalgia—Diethylpropion—obesity	0.00169	0.00617	CcSEcCtD
Fosamprenavir—Dizziness—Benzphetamine—obesity	0.00165	0.00603	CcSEcCtD
Fosamprenavir—Headache—Methamphetamine—obesity	0.00162	0.00593	CcSEcCtD
Fosamprenavir—Myalgia—Cimetidine—obesity	0.00161	0.00587	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Phentermine—obesity	0.00161	0.00587	CcSEcCtD
Fosamprenavir—Fatigue—Phentermine—obesity	0.0016	0.00586	CcSEcCtD
Fosamprenavir—Nephrolithiasis—Topiramate—obesity	0.00159	0.00582	CcSEcCtD
Fosamprenavir—Headache—Benzphetamine—obesity	0.00156	0.00571	CcSEcCtD
Fosamprenavir—Diarrhoea—Phendimetrazine—obesity	0.00156	0.00569	CcSEcCtD
Fosamprenavir—Gastritis—Orlistat—obesity	0.00153	0.00559	CcSEcCtD
Fosamprenavir—Aspartate aminotransferase increased—Sibutramine—obesity	0.00151	0.00551	CcSEcCtD
Fosamprenavir—Dizziness—Phendimetrazine—obesity	0.0015	0.0055	CcSEcCtD
Fosamprenavir—Nausea—Benzphetamine—obesity	0.00148	0.00542	CcSEcCtD
Fosamprenavir—Gastritis—Sibutramine—obesity	0.00148	0.00541	CcSEcCtD
Fosamprenavir—Alanine aminotransferase increased—Sibutramine—obesity	0.00148	0.00539	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Diethylpropion—obesity	0.00147	0.00539	CcSEcCtD
Fosamprenavir—Abdominal pain—Phentermine—obesity	0.00147	0.00537	CcSEcCtD
Fosamprenavir—Hypersensitivity—Phenylpropanolamine—obesity	0.00143	0.00523	CcSEcCtD
Fosamprenavir—Headache—Phendimetrazine—obesity	0.00142	0.00521	CcSEcCtD
Fosamprenavir—Gastrooesophageal reflux disease—Topiramate—obesity	0.00142	0.00518	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Cimetidine—obesity	0.0014	0.00512	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Diethylpropion—obesity	0.0014	0.0051	CcSEcCtD
Fosamprenavir—Nausea—Phendimetrazine—obesity	0.00135	0.00494	CcSEcCtD
Fosamprenavir—Asthenia—Phentermine—obesity	0.00133	0.00488	CcSEcCtD
Fosamprenavir—Fatigue—Cimetidine—obesity	0.00133	0.00485	CcSEcCtD
Fosamprenavir—Hyperglycaemia—Sibutramine—obesity	0.0013	0.00477	CcSEcCtD
Fosamprenavir—Gastritis—Bupropion—obesity	0.00129	0.00472	CcSEcCtD
Fosamprenavir—Dizziness—Phenylpropanolamine—obesity	0.00128	0.0047	CcSEcCtD
Fosamprenavir—Diarrhoea—Phentermine—obesity	0.00127	0.00465	CcSEcCtD
Fosamprenavir—Acute coronary syndrome—Sibutramine—obesity	0.00127	0.00465	CcSEcCtD
Fosamprenavir—Myocardial infarction—Sibutramine—obesity	0.00126	0.00462	CcSEcCtD
Fosamprenavir—Vomiting—Phenylpropanolamine—obesity	0.00124	0.00451	CcSEcCtD
Fosamprenavir—Dizziness—Phentermine—obesity	0.00123	0.00449	CcSEcCtD
Fosamprenavir—Rash—Phenylpropanolamine—obesity	0.00123	0.00448	CcSEcCtD
Fosamprenavir—Dermatitis—Phenylpropanolamine—obesity	0.00122	0.00447	CcSEcCtD
Fosamprenavir—Body temperature increased—Cimetidine—obesity	0.00122	0.00445	CcSEcCtD
Fosamprenavir—Haemoglobin—Orlistat—obesity	0.0012	0.00439	CcSEcCtD
Fosamprenavir—Haemorrhage—Orlistat—obesity	0.0012	0.00437	CcSEcCtD
Fosamprenavir—Vomiting—Phentermine—obesity	0.00118	0.00432	CcSEcCtD
Fosamprenavir—Urinary tract disorder—Orlistat—obesity	0.00118	0.00432	CcSEcCtD
Fosamprenavir—Urethral disorder—Orlistat—obesity	0.00117	0.00428	CcSEcCtD
Fosamprenavir—Rash—Phentermine—obesity	0.00117	0.00428	CcSEcCtD
Fosamprenavir—Dermatitis—Phentermine—obesity	0.00117	0.00428	CcSEcCtD
Fosamprenavir—Headache—Phentermine—obesity	0.00116	0.00426	CcSEcCtD
Fosamprenavir—Haemoglobin—Sibutramine—obesity	0.00116	0.00425	CcSEcCtD
Fosamprenavir—Haemorrhage—Sibutramine—obesity	0.00116	0.00423	CcSEcCtD
Fosamprenavir—Nausea—Phenylpropanolamine—obesity	0.00115	0.00422	CcSEcCtD
Fosamprenavir—Hyperglycaemia—Bupropion—obesity	0.00114	0.00416	CcSEcCtD
Fosamprenavir—Hypersensitivity—Cimetidine—obesity	0.00113	0.00414	CcSEcCtD
Fosamprenavir—Stevens-Johnson syndrome—Bupropion—obesity	0.00111	0.00407	CcSEcCtD
Fosamprenavir—Acute coronary syndrome—Bupropion—obesity	0.00111	0.00405	CcSEcCtD
Fosamprenavir—Diarrhoea—Diethylpropion—obesity	0.00111	0.00404	CcSEcCtD
Fosamprenavir—Nausea—Phentermine—obesity	0.0011	0.00404	CcSEcCtD
Fosamprenavir—Asthenia—Cimetidine—obesity	0.0011	0.00404	CcSEcCtD
Fosamprenavir—Myocardial infarction—Bupropion—obesity	0.0011	0.00403	CcSEcCtD
Fosamprenavir—Immune system disorder—Orlistat—obesity	0.00108	0.00395	CcSEcCtD
Fosamprenavir—Dizziness—Diethylpropion—obesity	0.00107	0.00391	CcSEcCtD
Fosamprenavir—Diabetes mellitus—Topiramate—obesity	0.00107	0.0039	CcSEcCtD
Fosamprenavir—Diarrhoea—Cimetidine—obesity	0.00105	0.00385	CcSEcCtD
Fosamprenavir—Immune system disorder—Sibutramine—obesity	0.00105	0.00382	CcSEcCtD
Fosamprenavir—Malnutrition—Orlistat—obesity	0.00104	0.0038	CcSEcCtD
Fosamprenavir—Vomiting—Diethylpropion—obesity	0.00103	0.00376	CcSEcCtD
Fosamprenavir—Flatulence—Orlistat—obesity	0.00103	0.00375	CcSEcCtD
Fosamprenavir—Rash—Diethylpropion—obesity	0.00102	0.00373	CcSEcCtD
Fosamprenavir—Dermatitis—Diethylpropion—obesity	0.00102	0.00372	CcSEcCtD
Fosamprenavir—Dizziness—Cimetidine—obesity	0.00102	0.00372	CcSEcCtD
Fosamprenavir—Haemoglobin—Bupropion—obesity	0.00101	0.00371	CcSEcCtD
Fosamprenavir—Headache—Diethylpropion—obesity	0.00101	0.0037	CcSEcCtD
Fosamprenavir—Haemorrhage—Bupropion—obesity	0.00101	0.00369	CcSEcCtD
Fosamprenavir—Malnutrition—Sibutramine—obesity	0.00101	0.00368	CcSEcCtD
Fosamprenavir—Urinary tract disorder—Bupropion—obesity	0.000997	0.00364	CcSEcCtD
Fosamprenavir—Flatulence—Sibutramine—obesity	0.000993	0.00363	CcSEcCtD
Fosamprenavir—Connective tissue disorder—Bupropion—obesity	0.000992	0.00362	CcSEcCtD
Fosamprenavir—Urethral disorder—Bupropion—obesity	0.000989	0.00361	CcSEcCtD
Fosamprenavir—Vomiting—Cimetidine—obesity	0.000979	0.00358	CcSEcCtD
Fosamprenavir—Rash—Cimetidine—obesity	0.00097	0.00355	CcSEcCtD
Fosamprenavir—Dermatitis—Cimetidine—obesity	0.00097	0.00354	CcSEcCtD
Fosamprenavir—Headache—Cimetidine—obesity	0.000964	0.00352	CcSEcCtD
Fosamprenavir—Nausea—Diethylpropion—obesity	0.000961	0.00351	CcSEcCtD
Fosamprenavir—Erythema multiforme—Bupropion—obesity	0.000954	0.00349	CcSEcCtD
Fosamprenavir—Angioedema—Orlistat—obesity	0.000951	0.00348	CcSEcCtD
Fosamprenavir—Cardiac disorder—Bupropion—obesity	0.000937	0.00342	CcSEcCtD
Fosamprenavir—Angioedema—Sibutramine—obesity	0.000921	0.00336	CcSEcCtD
Fosamprenavir—Nausea—Cimetidine—obesity	0.000914	0.00334	CcSEcCtD
Fosamprenavir—Immune system disorder—Bupropion—obesity	0.000911	0.00333	CcSEcCtD
Fosamprenavir—Myalgia—Orlistat—obesity	0.000886	0.00324	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.00088	0.00322	CcSEcCtD
Fosamprenavir—Malnutrition—Bupropion—obesity	0.000878	0.00321	CcSEcCtD
Fosamprenavir—Flatulence—Bupropion—obesity	0.000866	0.00316	CcSEcCtD
Fosamprenavir—Myalgia—Sibutramine—obesity	0.000858	0.00314	CcSEcCtD
Fosamprenavir—Aspartate aminotransferase increased—Topiramate—obesity	0.000837	0.00306	CcSEcCtD
Fosamprenavir—Nervous system disorder—Orlistat—obesity	0.000833	0.00305	CcSEcCtD
Fosamprenavir—Skin disorder—Orlistat—obesity	0.000825	0.00302	CcSEcCtD
Fosamprenavir—Gastritis—Topiramate—obesity	0.000822	0.00301	CcSEcCtD
Fosamprenavir—Alanine aminotransferase increased—Topiramate—obesity	0.00082	0.003	CcSEcCtD
Fosamprenavir—Angioedema—Bupropion—obesity	0.000803	0.00293	CcSEcCtD
Fosamprenavir—Skin disorder—Sibutramine—obesity	0.000799	0.00292	CcSEcCtD
Fosamprenavir—Anorexia—Sibutramine—obesity	0.000784	0.00286	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Orlistat—obesity	0.000774	0.00283	CcSEcCtD
Fosamprenavir—Neutropenia—Topiramate—obesity	0.000751	0.00274	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Sibutramine—obesity	0.000749	0.00274	CcSEcCtD
Fosamprenavir—Myalgia—Bupropion—obesity	0.000748	0.00273	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000743	0.00271	CcSEcCtD
Fosamprenavir—Decreased appetite—Orlistat—obesity	0.000739	0.0027	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Orlistat—obesity	0.000734	0.00268	CcSEcCtD
Fosamprenavir—Fatigue—Orlistat—obesity	0.000733	0.00268	CcSEcCtD
Fosamprenavir—Hyperglycaemia—Topiramate—obesity	0.000725	0.00265	CcSEcCtD
Fosamprenavir—Decreased appetite—Sibutramine—obesity	0.000715	0.00261	CcSEcCtD
Fosamprenavir—Stevens-Johnson syndrome—Topiramate—obesity	0.00071	0.00259	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Sibutramine—obesity	0.00071	0.00259	CcSEcCtD
Fosamprenavir—Nervous system disorder—Bupropion—obesity	0.000703	0.00257	CcSEcCtD
Fosamprenavir—Skin disorder—Bupropion—obesity	0.000696	0.00254	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Orlistat—obesity	0.000695	0.00254	CcSEcCtD
Fosamprenavir—Anorexia—Bupropion—obesity	0.000683	0.0025	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Sibutramine—obesity	0.000672	0.00246	CcSEcCtD
Fosamprenavir—Abdominal pain—Orlistat—obesity	0.000672	0.00245	CcSEcCtD
Fosamprenavir—Body temperature increased—Orlistat—obesity	0.000672	0.00245	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Bupropion—obesity	0.000653	0.00239	CcSEcCtD
Fosamprenavir—Body temperature increased—Sibutramine—obesity	0.00065	0.00238	CcSEcCtD
Fosamprenavir—Abdominal pain—Sibutramine—obesity	0.00065	0.00238	CcSEcCtD
Fosamprenavir—Haemoglobin—Topiramate—obesity	0.000646	0.00236	CcSEcCtD
Fosamprenavir—Haemorrhage—Topiramate—obesity	0.000643	0.00235	CcSEcCtD
Fosamprenavir—Urinary tract disorder—Topiramate—obesity	0.000635	0.00232	CcSEcCtD
Fosamprenavir—Connective tissue disorder—Topiramate—obesity	0.000632	0.00231	CcSEcCtD
Fosamprenavir—Urethral disorder—Topiramate—obesity	0.00063	0.0023	CcSEcCtD
Fosamprenavir—Hypersensitivity—Orlistat—obesity	0.000626	0.00229	CcSEcCtD
Fosamprenavir—Decreased appetite—Bupropion—obesity	0.000623	0.00228	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Bupropion—obesity	0.000619	0.00226	CcSEcCtD
Fosamprenavir—Fatigue—Bupropion—obesity	0.000618	0.00226	CcSEcCtD
Fosamprenavir—Asthenia—Orlistat—obesity	0.00061	0.00223	CcSEcCtD
Fosamprenavir—Erythema multiforme—Topiramate—obesity	0.000608	0.00222	CcSEcCtD
Fosamprenavir—Hypersensitivity—Sibutramine—obesity	0.000606	0.00221	CcSEcCtD
Fosamprenavir—Pruritus—Orlistat—obesity	0.000601	0.0022	CcSEcCtD
Fosamprenavir—Cardiac disorder—Topiramate—obesity	0.000597	0.00218	CcSEcCtD
Fosamprenavir—Asthenia—Sibutramine—obesity	0.00059	0.00216	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Bupropion—obesity	0.000586	0.00214	CcSEcCtD
Fosamprenavir—Pruritus—Sibutramine—obesity	0.000582	0.00213	CcSEcCtD
Fosamprenavir—Diarrhoea—Orlistat—obesity	0.000581	0.00212	CcSEcCtD
Fosamprenavir—Immune system disorder—Topiramate—obesity	0.000581	0.00212	CcSEcCtD
Fosamprenavir—CYP3A4—Irinotecan Pathway—NPC1—obesity	0.00057	0.0822	CbGpPWpGaD
Fosamprenavir—Body temperature increased—Bupropion—obesity	0.000567	0.00207	CcSEcCtD
Fosamprenavir—Abdominal pain—Bupropion—obesity	0.000567	0.00207	CcSEcCtD
Fosamprenavir—Diarrhoea—Sibutramine—obesity	0.000563	0.00206	CcSEcCtD
Fosamprenavir—Dizziness—Orlistat—obesity	0.000562	0.00205	CcSEcCtD
Fosamprenavir—Malnutrition—Topiramate—obesity	0.00056	0.00205	CcSEcCtD
Fosamprenavir—CYP3A4—Felbamate Metabolism—CYP2E1—obesity	0.000554	0.08	CbGpPWpGaD
Fosamprenavir—Flatulence—Topiramate—obesity	0.000551	0.00202	CcSEcCtD
Fosamprenavir—Dizziness—Sibutramine—obesity	0.000544	0.00199	CcSEcCtD
Fosamprenavir—Vomiting—Orlistat—obesity	0.00054	0.00197	CcSEcCtD
Fosamprenavir—Rash—Orlistat—obesity	0.000536	0.00196	CcSEcCtD
Fosamprenavir—Dermatitis—Orlistat—obesity	0.000535	0.00196	CcSEcCtD
Fosamprenavir—Headache—Orlistat—obesity	0.000532	0.00195	CcSEcCtD
Fosamprenavir—Hypersensitivity—Bupropion—obesity	0.000528	0.00193	CcSEcCtD
Fosamprenavir—Vomiting—Sibutramine—obesity	0.000523	0.00191	CcSEcCtD
Fosamprenavir—Rash—Sibutramine—obesity	0.000519	0.00189	CcSEcCtD
Fosamprenavir—Dermatitis—Sibutramine—obesity	0.000518	0.00189	CcSEcCtD
Fosamprenavir—Headache—Sibutramine—obesity	0.000515	0.00188	CcSEcCtD
Fosamprenavir—Asthenia—Bupropion—obesity	0.000514	0.00188	CcSEcCtD
Fosamprenavir—Pruritus—Bupropion—obesity	0.000507	0.00185	CcSEcCtD
Fosamprenavir—Nausea—Orlistat—obesity	0.000505	0.00184	CcSEcCtD
Fosamprenavir—Diarrhoea—Bupropion—obesity	0.000491	0.00179	CcSEcCtD
Fosamprenavir—Nausea—Sibutramine—obesity	0.000488	0.00179	CcSEcCtD
Fosamprenavir—Myalgia—Topiramate—obesity	0.000476	0.00174	CcSEcCtD
Fosamprenavir—Dizziness—Bupropion—obesity	0.000474	0.00173	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000473	0.00173	CcSEcCtD
Fosamprenavir—Vomiting—Bupropion—obesity	0.000456	0.00167	CcSEcCtD
Fosamprenavir—Rash—Bupropion—obesity	0.000452	0.00165	CcSEcCtD
Fosamprenavir—Dermatitis—Bupropion—obesity	0.000452	0.00165	CcSEcCtD
Fosamprenavir—Headache—Bupropion—obesity	0.000449	0.00164	CcSEcCtD
Fosamprenavir—Nervous system disorder—Topiramate—obesity	0.000448	0.00164	CcSEcCtD
Fosamprenavir—Skin disorder—Topiramate—obesity	0.000444	0.00162	CcSEcCtD
Fosamprenavir—Anorexia—Topiramate—obesity	0.000435	0.00159	CcSEcCtD
Fosamprenavir—Nausea—Bupropion—obesity	0.000426	0.00156	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Topiramate—obesity	0.000416	0.00152	CcSEcCtD
Fosamprenavir—Decreased appetite—Topiramate—obesity	0.000397	0.00145	CcSEcCtD
Fosamprenavir—CYP3A4—Irinotecan Pathway—CES1—obesity	0.000395	0.057	CbGpPWpGaD
Fosamprenavir—Gastrointestinal disorder—Topiramate—obesity	0.000394	0.00144	CcSEcCtD
Fosamprenavir—Fatigue—Topiramate—obesity	0.000394	0.00144	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Topiramate—obesity	0.000373	0.00136	CcSEcCtD
Fosamprenavir—Body temperature increased—Topiramate—obesity	0.000361	0.00132	CcSEcCtD
Fosamprenavir—Abdominal pain—Topiramate—obesity	0.000361	0.00132	CcSEcCtD
Fosamprenavir—Hypersensitivity—Topiramate—obesity	0.000337	0.00123	CcSEcCtD
Fosamprenavir—CYP3A4—Liver X Receptor Pathway—SCD—obesity	0.000333	0.0481	CbGpPWpGaD
Fosamprenavir—Asthenia—Topiramate—obesity	0.000328	0.0012	CcSEcCtD
Fosamprenavir—Pruritus—Topiramate—obesity	0.000323	0.00118	CcSEcCtD
Fosamprenavir—Diarrhoea—Topiramate—obesity	0.000313	0.00114	CcSEcCtD
Fosamprenavir—Dizziness—Topiramate—obesity	0.000302	0.0011	CcSEcCtD
Fosamprenavir—Vomiting—Topiramate—obesity	0.00029	0.00106	CcSEcCtD
Fosamprenavir—Rash—Topiramate—obesity	0.000288	0.00105	CcSEcCtD
Fosamprenavir—Dermatitis—Topiramate—obesity	0.000288	0.00105	CcSEcCtD
Fosamprenavir—Headache—Topiramate—obesity	0.000286	0.00105	CcSEcCtD
Fosamprenavir—Nausea—Topiramate—obesity	0.000271	0.000991	CcSEcCtD
Fosamprenavir—CYP3A4—Estrogen metabolism—STS—obesity	0.000194	0.0279	CbGpPWpGaD
Fosamprenavir—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—obesity	0.00019	0.0275	CbGpPWpGaD
Fosamprenavir—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—obesity	0.000187	0.0269	CbGpPWpGaD
Fosamprenavir—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I3—obesity	0.000181	0.0261	CbGpPWpGaD
Fosamprenavir—CYP3A4—Liver X Receptor Pathway—SREBF1—obesity	0.000167	0.0241	CbGpPWpGaD
Fosamprenavir—CYP3A4—Farnesoid X Receptor  Pathway—NR0B2—obesity	0.000165	0.0238	CbGpPWpGaD
Fosamprenavir—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—obesity	0.000165	0.0238	CbGpPWpGaD
Fosamprenavir—CYP3A4—Liver X Receptor Pathway—FASN—obesity	0.000159	0.023	CbGpPWpGaD
Fosamprenavir—CYP3A4—Drug Induction of Bile Acid Pathway—SULT2A1—obesity	0.000137	0.0197	CbGpPWpGaD
Fosamprenavir—CYP3A4—Farnesoid X Receptor  Pathway—SULT2A1—obesity	0.000125	0.0181	CbGpPWpGaD
Fosamprenavir—CYP3A4—Irinotecan Pathway—BCHE—obesity	0.000121	0.0175	CbGpPWpGaD
Fosamprenavir—CYP3A4—Tamoxifen metabolism—SULT2A1—obesity	0.000116	0.0167	CbGpPWpGaD
Fosamprenavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARD—obesity	0.000114	0.0164	CbGpPWpGaD
Fosamprenavir—CYP3A4—Constitutive Androstane Receptor Pathway—NR1I3—obesity	0.000109	0.0157	CbGpPWpGaD
Fosamprenavir—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—obesity	0.000105	0.0152	CbGpPWpGaD
Fosamprenavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—obesity	0.000104	0.015	CbGpPWpGaD
Fosamprenavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—obesity	9.49e-05	0.0137	CbGpPWpGaD
Fosamprenavir—CYP3A4—Estrogen metabolism—NQO1—obesity	9.45e-05	0.0136	CbGpPWpGaD
Fosamprenavir—CYP3A4—Oxidation by Cytochrome P450—CYB5A—obesity	9.22e-05	0.0133	CbGpPWpGaD
Fosamprenavir—CYP3A4—Xenobiotics—CYP2E1—obesity	8.79e-05	0.0127	CbGpPWpGaD
Fosamprenavir—CYP3A4—Tamoxifen metabolism—CYP2E1—obesity	8.45e-05	0.0122	CbGpPWpGaD
Fosamprenavir—CYP3A4—Aflatoxin activation and detoxification—GGT1—obesity	8.41e-05	0.0121	CbGpPWpGaD
Fosamprenavir—CYP3A4—Constitutive Androstane Receptor Pathway—SULT2A1—obesity	8.25e-05	0.0119	CbGpPWpGaD
Fosamprenavir—CYP3A4—Tryptophan metabolism—ECHS1—obesity	8.14e-05	0.0118	CbGpPWpGaD
Fosamprenavir—CYP3A4—Estrogen metabolism—COMT—obesity	7.92e-05	0.0114	CbGpPWpGaD
Fosamprenavir—CYP3A4—Tryptophan metabolism—HADH—obesity	7.66e-05	0.011	CbGpPWpGaD
Fosamprenavir—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—obesity	7.48e-05	0.0108	CbGpPWpGaD
Fosamprenavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26B1—obesity	7.39e-05	0.0107	CbGpPWpGaD
Fosamprenavir—CYP3A4—Oxidation by Cytochrome P450—CYP26B1—obesity	7.29e-05	0.0105	CbGpPWpGaD
Fosamprenavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP26B1—obesity	5.99e-05	0.00864	CbGpPWpGaD
Fosamprenavir—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—obesity	5.83e-05	0.00842	CbGpPWpGaD
Fosamprenavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—obesity	5.75e-05	0.00829	CbGpPWpGaD
Fosamprenavir—CYP3A4—Constitutive Androstane Receptor Pathway—NCOA1—obesity	5.46e-05	0.00787	CbGpPWpGaD
Fosamprenavir—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—obesity	5.25e-05	0.00758	CbGpPWpGaD
Fosamprenavir—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—obesity	4.93e-05	0.00711	CbGpPWpGaD
Fosamprenavir—CYP3A4—Tryptophan metabolism—CYP2E1—obesity	4.51e-05	0.00651	CbGpPWpGaD
Fosamprenavir—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—obesity	4.46e-05	0.00643	CbGpPWpGaD
Fosamprenavir—CYP3A4—Tryptophan metabolism—CYP19A1—obesity	4.02e-05	0.0058	CbGpPWpGaD
Fosamprenavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—obesity	3.78e-05	0.00545	CbGpPWpGaD
Fosamprenavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—obesity	3.65e-05	0.00527	CbGpPWpGaD
Fosamprenavir—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—obesity	3.6e-05	0.0052	CbGpPWpGaD
Fosamprenavir—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA1—obesity	3.3e-05	0.00476	CbGpPWpGaD
Fosamprenavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—obesity	3.25e-05	0.00469	CbGpPWpGaD
Fosamprenavir—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—obesity	3.21e-05	0.00463	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—CYP26B1—obesity	3.18e-05	0.00459	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metapathway biotransformation—CYP26B1—obesity	3.14e-05	0.00453	CbGpPWpGaD
Fosamprenavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—obesity	3.12e-05	0.0045	CbGpPWpGaD
Fosamprenavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—obesity	2.96e-05	0.00427	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—ADH1B—obesity	2.79e-05	0.00403	CbGpPWpGaD
Fosamprenavir—CYP3A4—Phase 1 - Functionalization of compounds—NCOA1—obesity	2.68e-05	0.00386	CbGpPWpGaD
Fosamprenavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—obesity	2.64e-05	0.0038	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—SULT2A1—obesity	2.15e-05	0.0031	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metapathway biotransformation—SULT2A1—obesity	2.12e-05	0.00306	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metapathway biotransformation—GPX3—obesity	2.02e-05	0.00292	CbGpPWpGaD
Fosamprenavir—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—obesity	1.95e-05	0.00282	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metapathway biotransformation—AKR1C3—obesity	1.77e-05	0.00256	CbGpPWpGaD
Fosamprenavir—CYP3A4—Phase 1 - Functionalization of compounds—POMC—obesity	1.58e-05	0.00229	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—CYP2E1—obesity	1.57e-05	0.00227	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metapathway biotransformation—CYP2E1—obesity	1.55e-05	0.00224	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—GGT1—obesity	1.44e-05	0.00208	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—NCOA1—obesity	1.42e-05	0.00205	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—CYP19A1—obesity	1.4e-05	0.00202	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metapathway biotransformation—CYP19A1—obesity	1.38e-05	0.00199	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CA3—obesity	1.31e-05	0.00189	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—COMT—obesity	1.3e-05	0.00188	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metapathway biotransformation—COMT—obesity	1.28e-05	0.00185	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—GLRX—obesity	1.11e-05	0.00161	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—PPM1L—obesity	9.93e-06	0.00143	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—OTC—obesity	9.93e-06	0.00143	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—INSIG2—obesity	9.93e-06	0.00143	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ETFDH—obesity	9.93e-06	0.00143	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—UQCRC2—obesity	9.08e-06	0.00131	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—GPT—obesity	9.08e-06	0.00131	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—INPP5E—obesity	9.08e-06	0.00131	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—SUCLG2—obesity	8.44e-06	0.00122	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ALDH6A1—obesity	8.44e-06	0.00122	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ME1—obesity	8.44e-06	0.00122	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—POMC—obesity	8.42e-06	0.00121	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—PNPLA3—obesity	7.94e-06	0.00115	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—UCP1—obesity	7.94e-06	0.00115	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—COX7C—obesity	7.94e-06	0.00115	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—DGAT2—obesity	7.53e-06	0.00109	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CS—obesity	7.53e-06	0.00109	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—SUCLA2—obesity	7.53e-06	0.00109	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CPS1—obesity	7.53e-06	0.00109	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—LIPE—obesity	7.18e-06	0.00104	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—MUT—obesity	7.18e-06	0.00104	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CYB5A—obesity	6.88e-06	0.000993	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—DGAT1—obesity	6.88e-06	0.000993	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ACLY—obesity	6.63e-06	0.000956	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ENPP1—obesity	6.4e-06	0.000923	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ALOX12—obesity	6.4e-06	0.000923	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—HMGCS1—obesity	6.2e-06	0.000894	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—PLIN1—obesity	6.02e-06	0.000868	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—PNPLA2—obesity	6.02e-06	0.000868	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—SAT1—obesity	6.02e-06	0.000868	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—PFKFB3—obesity	6.02e-06	0.000868	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ANGPTL4—obesity	6.02e-06	0.000868	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ACADM—obesity	6.02e-06	0.000868	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ACACB—obesity	5.85e-06	0.000844	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—OXCT1—obesity	5.85e-06	0.000844	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CYTB—obesity	5.85e-06	0.000844	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—PNLIP—obesity	5.7e-06	0.000823	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—SRD5A1—obesity	5.7e-06	0.000823	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—SDC3—obesity	5.57e-06	0.000803	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—HK2—obesity	5.44e-06	0.000785	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—STS—obesity	5.44e-06	0.000785	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CYP26B1—obesity	5.44e-06	0.000785	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—PPARD—obesity	5.32e-06	0.000768	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—SLC27A1—obesity	5.22e-06	0.000753	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—FABP4—obesity	5.12e-06	0.000738	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—GLUL—obesity	5.12e-06	0.000738	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—UCP3—obesity	4.85e-06	0.0007	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—UCP2—obesity	4.85e-06	0.0007	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—HSD11B1—obesity	4.85e-06	0.0007	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ECHS1—obesity	4.85e-06	0.0007	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ADH1B—obesity	4.77e-06	0.000688	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—GPAM—obesity	4.7e-06	0.000678	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—PPARGC1B—obesity	4.7e-06	0.000678	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ACSL1—obesity	4.7e-06	0.000678	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—HADH—obesity	4.56e-06	0.000658	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—FADS1—obesity	4.56e-06	0.000658	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—PCK1—obesity	4.56e-06	0.000658	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ACP5—obesity	4.44e-06	0.00064	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—G6PD—obesity	4.32e-06	0.000624	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—HK1—obesity	4.27e-06	0.000616	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—SREBF2—obesity	4.27e-06	0.000616	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—LPA—obesity	4.12e-06	0.000595	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—LPIN1—obesity	4.04e-06	0.000582	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—APOA5—obesity	3.95e-06	0.00057	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CLOCK—obesity	3.77e-06	0.000544	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—SLC22A1—obesity	3.77e-06	0.000544	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—SULT2A1—obesity	3.68e-06	0.00053	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—GLP1R—obesity	3.68e-06	0.00053	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—DPYD—obesity	3.62e-06	0.000522	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—PRKAR2B—obesity	3.48e-06	0.000502	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—DCN—obesity	3.46e-06	0.000499	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CPT1A—obesity	3.36e-06	0.000485	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—NAMPT—obesity	3.3e-06	0.000476	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—LIPC—obesity	3.28e-06	0.000473	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—GCK—obesity	3.28e-06	0.000473	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—APOC3—obesity	3.26e-06	0.00047	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CETP—obesity	3.16e-06	0.000456	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—SDC1—obesity	3.12e-06	0.000451	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—AKR1C3—obesity	3.07e-06	0.000444	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—SCARB1—obesity	3.03e-06	0.000437	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—SREBF1—obesity	2.94e-06	0.000424	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—GOT2—obesity	2.86e-06	0.000412	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—FASN—obesity	2.8e-06	0.000404	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—BCHE—obesity	2.79e-06	0.000402	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CYP2E1—obesity	2.69e-06	0.000388	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—NQO1—obesity	2.66e-06	0.000383	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—SLC2A4—obesity	2.55e-06	0.000368	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—GCG—obesity	2.55e-06	0.000368	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CYCS—obesity	2.51e-06	0.000363	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—GOT1—obesity	2.47e-06	0.000356	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—GGT1—obesity	2.47e-06	0.000356	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—NCOA1—obesity	2.43e-06	0.000351	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—STK11—obesity	2.4e-06	0.000346	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CYP19A1—obesity	2.4e-06	0.000346	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—COMT—obesity	2.23e-06	0.000321	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—PPARGC1A—obesity	2.2e-06	0.000317	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—GNB3—obesity	2.2e-06	0.000317	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—HMOX1—obesity	2.19e-06	0.000315	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—GNAS—obesity	2.14e-06	0.000308	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—APOB—obesity	2.09e-06	0.000302	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—LPL—obesity	2e-06	0.000288	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—GPX1—obesity	1.95e-06	0.000281	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CD36—obesity	1.9e-06	0.000274	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—MTHFR—obesity	1.8e-06	0.00026	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—PPARA—obesity	1.77e-06	0.000255	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—AGT—obesity	1.71e-06	0.000247	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—APOE—obesity	1.68e-06	0.000242	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CAV1—obesity	1.66e-06	0.00024	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—APOA1—obesity	1.66e-06	0.000239	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—PIK3CG—obesity	1.51e-06	0.000218	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—PPARG—obesity	1.46e-06	0.000211	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—POMC—obesity	1.44e-06	0.000208	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—INS—obesity	1.43e-06	0.000207	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—PIK3CD—obesity	1.33e-06	0.000192	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ALB—obesity	1.31e-06	0.000189	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—PIK3R1—obesity	1.26e-06	0.000181	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—NOS3—obesity	1.26e-06	0.000181	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—PIK3CB—obesity	1.16e-06	0.000167	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—PTGS2—obesity	1.15e-06	0.000166	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—PIK3CA—obesity	7.06e-07	0.000102	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—AKT1—obesity	5.77e-07	8.33e-05	CbGpPWpGaD
